Table 2 Prevalence of comorbidities and agreement between data derived from medical charts and administrative data (n = 3471)
Comorbidities | Medical charts No. (%) | Administrative data No. (%) | Kappa (95% CI) |
|---|---|---|---|
Diabetes, uncomplicated | 996 (28.7) | 900 (25.9) | 0.78 (0.77 - 0.80) |
Metastatic cancer | 116 (3.3) | 112 (3.2) | 0.71 (0.70 - 0.73) |
Diabetes, complicated | 203 (5.8) | 256 (7.4) | 0.69 (0.67 - 0.71) |
Chronic pulmonary disease | 561 (16.2) | 417 (12.0) | 0.54 (0.53 - 0.56) |
Lymphoma | 20 (0.6) | 17 (0.5) | 0.54 (0.52 - 0.56) |
Alcohol abuse | 33 (1.0) | 23 (0.7) | 0.53 (0.52 - 0.55) |
Hypertension | 2068 (59.6) | 1190 (34.3) | 0.45 (0.44 - 0.47) |
Peripheral vascular disorders | 199 (5.7) | 94 (2.7) | 0.44 (0.43 - 0.46) |
Liver disease | 109 (3.1) | 57 (1.6) | 0.43 (0.42 - 0.45) |
Congestive heart failure | 469 (13.5) | 252 (7.3) | 0.40 (0.39 - 0.42) |
RA/Collagen vascular disease | 43 (1.2) | 12 (0.3) | 0.36 (0.35 - 0.37) |
Cardiac arrhythmias | 489 (14.1) | 222 (6.4) | 0.34 (0.33 - 0.36) |
Coagulopathy | 118 (3.4) | 271 (7.8) | 0.33 (0.32 - 0.35) |
Hypothyroidism | 118 (3.4) | 40 (1.2) | 0.33 (0.32 - 0.35) |
Other neurological disorders | 426 (12.3) | 142 (4.1) | 0.33 (0.31 - 0.34) |
Solid tumor without metastasis | 363 (10.5) | 200 (5.8) | 0.32 (0.30 - 0.34) |
Fluid and electrolyte disorders | 942 (27.1) | 712 (20.5) | 0.32 (0.30 - 0.33) |
Deficiency anemias | 474 (13.7) | 704 (20.3) | 0.28 (0.26 - 0.29) |
Valvular disease | 98 (2.8) | 38 (1.1) | 0.21 (0.19 - 0.22) |
Pulmonary circulation disorders | 44 (1.3) | 16 (0.5) | 0.20 (0.18 - 0.21) |
Psychoses | 97 (2.8) | 13 (0.4) | 0.14 (0.13 - 0.15) |
Weight loss | 18 (0.5) | 82 (2.4) | 0.13 (0.12 - 0.15) |
Depression | 319 (9.2) | 33 (1.0) | 0.08 (0.07 - 0.09) |
Renal failure | 447 (12.9) | 24 (0.7) | 0.06 (0.05 - 0.07) |
Peptic ulcer disease | 174 (5.0) | 16 (0.5) | 0.05 (0.04 - 0.05) |
Blood loss anemia | 3 (0.1) | 57 (1.6) | 0.03 (0.02 - 0.04) |
Paralysis | 16 (0.5) | 128 (3.7) | 0.01 (-0.01 - 0.02) |